Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 16,029.03% vs 0.00% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 16.12% vs 6.01% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 17.57% vs 7.11% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 96.67% vs 114.29% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Oncolys BioPharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 16,029.03% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1,654.39% vs -9.24% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 16.12% vs 6.01% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 30.68% vs -28.42% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 17.57% vs 7.11% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 28.03% vs -16.26% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 96.67% vs 114.29% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 391.67% vs 20.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






